Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cepham is a private U.S.-based nutraceutical ingredients company that develops, manufactures, and distributes evidence-based botanical extracts, phytochemicals, branded ingredients, and related delivery systems for the natural health industry. Founded in 1978, the company combines ingredient discovery, natural products research, clinical support, manufacturing, and global sourcing across operations in the U.S., India, and Africa. Its portfolio is focused on ingredients used in dietary supplements, functional foods, and nutritional beverages, with emphasis on metabolic health, cognitive health, women’s health, men’s health, and healthy aging. Cepham positions itself as a vertically integrated supplier with in-house and partner capabilities spanning research, crop sourcing, extraction, processing, quality control, and distribution. The company also highlights supply-chain transparency and blockchain-enabled traceability for selected ingredient programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cepham.